KUKJEON PHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,106	46,824	10,992	21,546	19,099
Short-Term Investments	-	-	15,000	45,000	20,160
Trading Asset Securities	16,462	-	38,840	28,425	-
Cash & Short-Term Investments	23,568	46,824	64,833	94,971	39,259
Cash Growth	-66.96%	-27.78%	-31.73%	141.91%	-
Accounts Receivable	24,327	28,779	26,850	21,923	20,015
Other Receivables	296.47	66.66	1,964	867.93	194.62
Receivables	25,083	29,255	29,065	23,403	20,409
Inventory	21,210	26,798	27,563	20,209	16,207
Prepaid Expenses	-	538.53	494.91	246.48	143.8
Other Current Assets	1,868	1,773	2,036	4,064	896.09
Total Current Assets	71,729	105,189	123,992	142,893	76,915
Property, Plant & Equipment	86,076	87,360	86,060	46,118	24,026
Long-Term Investments	5,076	5,322	4,364	3,173	3,493
Goodwill	420.39	420.39	420.39	420.39	-
Other Intangible Assets	869.81	908.17	971	903.51	422.37
Long-Term Deferred Tax Assets	2,817	2,185	1,964	-	794.9
Long-Term Deferred Charges	3,500	3,500	-	-	-
Other Long-Term Assets	7,109	7,169	7,090	2,379	517.79
Total Assets	177,778	212,273	225,102	196,097	106,989
Accounts Payable	10,127	17,833	11,693	9,474	10,989
Accrued Expenses	334.3	359.99	289.73	178.99	83.02
Short-Term Debt	25,675	8,560	15,224	7,883	5,133
Current Portion of Long-Term Debt	2,557	31,819	36,802	26,015	1,457
Current Portion of Leases	178.07	274.88	236.17	147.15	124.88
Current Income Taxes Payable	-	-	-	-	1,057
Current Unearned Revenue	-	-	35.16	-	-
Other Current Liabilities	23,185	29,729	35,542	26,993	3,007
Total Current Liabilities	62,056	88,576	99,823	70,691	21,852
Long-Term Debt	15,654	24,035	26,183	25,091	942.84
Long-Term Leases	582.75	622.23	334.14	202.84	193.97
Pension & Post-Retirement Benefits	-	-0	-0	-0	-0
Long-Term Deferred Tax Liabilities	-	10.45	10.45	1,365	-
Other Long-Term Liabilities	1,078	1,529	1,296	6,425	849.76
Total Liabilities	79,370	114,774	127,646	103,774	23,838
Common Stock	5,018	4,907	4,907	4,907	4,907
Additional Paid-In Capital	65,713	62,139	62,386	62,386	62,397
Retained Earnings	27,989	30,375	29,129	24,305	15,848
Treasury Stock	-1.16	-1.16	-1.16	-1.16	-1.16
Comprehensive Income & Other	0	-0	0	0	0
Total Common Equity	98,719	97,420	96,422	91,597	83,150
Minority Interest	-311.35	79.38	1,035	725.74	-
Shareholders' Equity	98,407	97,499	97,456	92,323	83,150
Total Liabilities & Equity	177,778	212,273	225,102	196,097	106,989
Total Debt	44,647	65,312	78,780	59,339	7,852
Net Cash (Debt)	-21,079	-18,488	-13,947	35,632	31,407
Net Cash Growth	-	-	-	13.45%	-
Net Cash Per Share	-422.37	-376.77	-284.24	695.44	712.02
Filing Date Shares Outstanding	49.85	49.07	49.07	49.07	49.07
Total Common Shares Outstanding	49.85	49.07	49.07	49.07	49.07
Working Capital	9,673	16,613	24,169	72,202	55,063
Book Value Per Share	1980.18	1985.36	1965.01	1866.70	1694.56
Tangible Book Value	97,428	96,091	95,030	90,274	82,728
Tangible Book Value Per Share	1954.30	1958.28	1936.66	1839.72	1685.95
Land	20,694	20,224	19,837	15,613	3,997
Buildings	39,039	38,047	36,673	11,300	8,252
Machinery	31,783	30,295	22,297	11,051	7,554
Construction In Progress	362.53	624.1	6,407	13,388	9,214

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.